Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.11 is 98% above its 5-year average of -6.93, near the high end of its 5-year range (-9.98–-0.11).
96.56% above its 12-month average of -3.20.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.05.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:18:40.626Z. Historical observations retain their original dates. Historical series through 2026-08-06.
EARNINGS PER SHARE (EPS)
-0.11
EARNINGS PER SHARE (EPS) AVG TTM
-3.20
EARNINGS PER SHARE (EPS) AVG 3Y
-6.52
EARNINGS PER SHARE (EPS) AVG 5Y
-6.93
EARNINGS PER SHARE (EPS) AVG 10Y
-33.09
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+96.56%
CURRENT VS 3Y AVG
+98.31%
CURRENT VS 5Y AVG
+98.41%
CURRENT VS 10Y AVG
+99.67%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
vTv Therapeutics Inc.
Market Cap
$78.59M
Earnings Per Share (EPS)
-0.11
TTM Avg
-3.20
3Y Avg
-6.52
5Y Avg
-6.93
Market Cap
$78.29M
Earnings Per Share (EPS)
-0.67
TTM Avg
-0.83
3Y Avg
-1.06
5Y Avg
-1.10
Market Cap
$79.03M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.32
3Y Avg
-0.23
5Y Avg
-0.23
Market Cap
$78.07M
Earnings Per Share (EPS)
-1.17
TTM Avg
-2.88
3Y Avg
-6.48
5Y Avg
-4.74
Market Cap
$79.61M
Earnings Per Share (EPS)
-1.88
TTM Avg
-2.06
3Y Avg
-2.07
5Y Avg
-1.66
Market Cap
$77.54M
Earnings Per Share (EPS)
-2.22
TTM Avg
-3.23
3Y Avg
-3.23
5Y Avg
-3.23
Market Cap
$80.30M
Earnings Per Share (EPS)
-0.51
TTM Avg
-0.76
3Y Avg
-0.68
5Y Avg
-1.48
Market Cap
$76.74M
Earnings Per Share (EPS)
-4.09
TTM Avg
-21.16
3Y Avg
-36.34
5Y Avg
-37.75
Market Cap
$81.20M
Earnings Per Share (EPS)
-0.57
TTM Avg
-1.79
3Y Avg
-1.21
5Y Avg
-1.06
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| vTv Therapeutics Inc. (VTVT) | $78.59M | -0.11 | -3.20 | -6.52 | -6.93 |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | -0.67 | -0.83 | -1.06 | -1.10 |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | -0.48 | -0.32 | -0.23 | -0.23 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -1.17 | -2.88 | -6.48 | -4.74 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | -1.88 | -2.06 | -2.07 | -1.66 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | -2.22 | -3.23 | -3.23 | -3.23 |
| Humacyte, Inc. (HUMA)vs › | $80.30M | -0.51 | -0.76 | -0.68 | -1.48 |
| Outset Medical, Inc. (OM)vs › | $76.74M | -4.09 | -21.16 | -36.34 | -37.75 |
| Nutriband Inc. (NTRB)vs › | $81.20M | -0.57 | -1.79 | -1.21 | -1.06 |
| MediciNova, Inc. (MNOV)vs › | $81.22M | -0.22 | -0.23 | -0.23 | -0.24 |
Trailing EPS (TTM)
$-0.11
Forward EPS (Est.)
$-1.41
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.20 |
| 2024-12-31 | -3.20 |
| 2023-12-31 | -9.71 |
| 2022-12-31 | -9.98 |
| 2021-12-31 | -8.29 |
| 2020-12-31 | -7.21 |
| 2019-12-31 | -28.97 |
| 2018-12-31 | -25.42 |
| 2017-12-31 | -66.62 |
| 2016-12-31 | -68.52 |
| 2015-12-31 | -132.90 |
| 2014-12-31 | -173.87 |
| 2013-12-31 | -234.57 |
